Larry Zeitlin

Larry Zeitlin is the current president at Mapp Biopharmaceutical. Larry has previously worked as a senior scientist at Epicyte, research scientist at ReProtect, and president at Mapp Biopharmaceutical. Zeitlin has over 20 years of experience in the biotechnology industry.

Larry Zeitlin received a Bachelor's degree in Biophysics from Johns Hopkins University and then went on to receive a Doctor of Philosophy (Ph.D.) in Reproductive Biology from The Johns Hopkins University.

Larry Zeitlin reports to Kevin Whaley, CEO.